Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Here's A Review Of ENZC vs RGBP of Relative To February vs Today


ENZC had
#1 (1) Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No prospect of revenue (due to #2 & #3)
#8 No suggestion of Buy Out by CEO

RGBP has
#1 (24) Patents worth $ BILLIONS
https://patents.google.com/?inventor=David+Koos&sort=new

#2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine "The Future of Medicine" https://www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy

#3 FDA Patent Approval
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/

#4 Partnership:Oncology Pharma Paid $1.1M for Patent Licensing; RGBP is now positioned to Post Quarterly Revenues for 15 YEARS (This is indicative of a NASDAQ Stock unlike any OTC)

#5 Pink Current-World Wide Buying IN PROGRESS

#6 CEO suggests Buy Out:Filed 8K 4/27/21 to prevent Hostile Take Over that says "parties seeking to ACQUIRE must negotiate directly."